Skip to main content
Caplight Logo









Biom Pharmaceutical

Biom Pharmaceutical

Private
Sarasota, FloridaHealthcare & Life Scienceshttps://biompharma.com

Company Overview

Biom Pharmaceutical operates in Healthcare & Life Sciences and is based in Sarasota, Florida. It was founded in 2016.

Biom Pharmaceutical is a biotechnology company that develops microbiome-based nutritional supplements and therapeutic modalities for various diseases and age-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Biom Pharmaceutical Comparables

Compare Biom Pharmaceutical with similar companies based on industry and business-model similarity.

Biom Pharmaceutical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Notitia Biotechnologies
83%
OptiBiotix Health Plc
77%
Solarea Bio
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Biom Pharmaceutical Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Biom Pharmaceutical. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 42% MoM.

  • Nov 11, 2025

    Monthly visitors increased 40% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Biom Pharmaceutical Filings

Explore SEC and related filing metadata, where available.

Biom Pharmaceutical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Biom Pharmaceutical's valuation, stock price, and market status.

Is Biom Pharmaceutical a public or private company?

Biom Pharmaceutical is a private company.

What is the current stock price of Biom Pharmaceutical?

Biom Pharmaceutical is a private company, so its shares have no public market price. Caplight tracks Biom Pharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biom Pharmaceutical worth (valuation)?

Valuation information for Biom Pharmaceutical is not publicly available.

Can I buy Biom Pharmaceutical stock?

Biom Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biom Pharmaceutical's last funding round?

Funding round information for Biom Pharmaceutical is not publicly available.

Who are the main investors in Biom Pharmaceutical?

Investor information for Biom Pharmaceutical is not publicly disclosed.

Will Biom Pharmaceutical IPO soon?

No public IPO plans have been announced for Biom Pharmaceutical.

How can I track Biom Pharmaceutical secondary market activity?

Caplight tracks bids, offers, and trades in Biom Pharmaceutical's shares on secondary markets.

Firmographic Details

HeadquartersSarasota, Florida
Employee Range12
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?